citrulline and monomethyl auristatin e

citrulline has been researched along with monomethyl auristatin e in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Alley, SC; Benjamin, D; Carter, PJ; Gerber, HP; Grewal, IS; Hayes, B; Hernandez-Ilizaliturri, FJ; Kung-Sutherland, M; McCormick, R; McDonagh, CF; Miyamoto, J; Morris-Tilden, C; Okeley, N; Stone, I1
Alley, SC; Baker Lee, C; Benjamin, DR; Hengel, SM; Lyon, RP; Nicholas, ND; Sanderson, RJ1
Casanova, R; Gébleux, R; Neri, D; Soltermann, A; Stringhini, M1
Agarwal, P; Chen, SC; Fine, BM; Gibiansky, L; Girish, S; Jin, JY; Kågedal, M; Koppada, N; Li, C; Lu, D; Saad, O; Samineni, D; Wang, B; Wang, X; Xu, J1
Akita, RW; Caculitan, NG; Cheung, TK; Dela Cruz Chuh, J; Haley, B; Kozak, KR; Lee, BC; Liu, Y; Ma, Y; Phung, Q; Pillow, TH; Polson, AG; Sadowsky, J; Sliwkowski, MX; Zhang, D1
Fine, BM; Gillespie, WR; Girish, S; Jin, JY; Kågedal, M; Li, C; Lu, D; Samineni, D1
Chen, F; Dong, K; Dong, LH; Jiang, J; Li, L; Song, HF; Wang, L; Xu, MZ1

Other Studies

7 other study(ies) available for citrulline and monomethyl auristatin e

ArticleYear
Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
    Blood, 2009, Apr-30, Volume: 113, Issue:18

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Citrulline; Dimerization; Dipeptides; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Dosage; Humans; Immunoconjugates; Immunoenzyme Techniques; Lymphoma, Non-Hodgkin; Lysosomes; Mice; Mice, SCID; Oligopeptides; Receptors, Complement 3d; Rituximab; Valine; Xenograft Model Antitumor Assays

2009
Antibody-conjugated drug assay for protease-cleavable antibody-drug conjugates.
    Bioanalysis, 2016, Volume: 8, Issue:1

    Topics: Animals; Biological Assay; Citrulline; Drug Stability; Female; Humans; Immunoconjugates; Oligopeptides; Papain; Rats; Valine

2016
Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix.
    International journal of cancer, 2017, 04-01, Volume: 140, Issue:7

    Topics: Animals; Antibodies; Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Citrulline; Cricetulus; Endothelium; Extracellular Matrix; Female; Humans; Immunoconjugates; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Oligopeptides; Protein Isoforms; Tenascin; Valine

2017
Platform model describing pharmacokinetic properties of vc-MMAE antibody-drug conjugates.
    Journal of pharmacokinetics and pharmacodynamics, 2017, Volume: 44, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Citrulline; Cohort Studies; Female; Humans; Immunoconjugates; Male; Middle Aged; Models, Biological; Neoplasms; Oligopeptides; Valine; Young Adult

2017
Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
    Cancer research, 2017, 12-15, Volume: 77, Issue:24

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Cells, Cultured; Citrulline; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Immunoconjugates; Oligopeptides; Prodrugs; Proteolysis; Valine

2017
Time-to-Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine-Citrulline-Monomethylauristatin E Antibody-Drug Conjugates.
    CPT: pharmacometrics & systems pharmacology, 2019, Volume: 8, Issue:8

    Topics: Body Weight; Citrulline; Clinical Trials as Topic; Drug Dosage Calculations; Female; Humans; Immunoconjugates; Male; Models, Biological; Neoplasms; Oligopeptides; Peripheral Nervous System Diseases; Time Factors; Valine

2019
Conjugating MMAE to a novel anti-HER2 antibody for selective targeted delivery.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:24

    Topics: Animals; Antibodies, Monoclonal; Cell Proliferation; Cell Survival; Citrulline; Drug Delivery Systems; Female; Immunoconjugates; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Oligopeptides; Receptor, ErbB-2; Tumor Cells, Cultured; Valine

2020